JoVE Logo
Faculty Resource Center

Sign In

Development of a Negative Selectable Marker for Entamoeba histolytica

DOI :

10.3791/2410-v

6:05 min

December 12th, 2010

December 12th, 2010

12,095 Views

1Division of Infectious Disease and International Health, University of Virginia Health System

We report development of a negative selection system in E. histolytica based upon transgenic expression of a chimeric protein (FCU1) and selection with the prodrug 5-fluorocytosine. The FCU1 protein is a fusion of yeast cytosine deaminase and uracil phosphoribosyltransferase. Expression of FCU1 resulted in increased E. histolytica sensitivity towards 5-fluorocytosine.

Tags

Negative Selectable Marker

-- Views

Related Videos

article

In vitro tRNA Methylation Assay with the Entamoeba histolytica DNA and tRNA Methyltransferase Dnmt2 (Ehmeth) Enzyme

article

Examination of Thymic Positive and Negative Selection by Flow Cytometry

article

Using Click Chemistry to Measure the Effect of Viral Infection on Host-Cell RNA Synthesis

article

Rapid Identification of Gram Negative Bacteria from Blood Culture Broth Using MALDI-TOF Mass Spectrometry

article

Analysis of the Epithelial Damage Produced by Entamoeba histolytica Infection

article

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology

article

Visualizing the Effects of Sputum on Biofilm Development Using a Chambered Coverglass Model

article

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

article

Utilization of Capsules for Negative Staining of Viral Samples within Biocontainment

article

Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved